T&L Co., Ltd. has completed an IPO in the amount of KRW 28.8 billion.
November 16, 2020 at 12:00 am
Share
T&L Co., Ltd. has completed an IPO in the amount of KRW 28.8 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 800,000
PriceRange: KRW 36000
Discount Per Security: KRW 1080
Transaction Features: ESOP Related Offering
T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
T&L CO., LTD. 
